Yubo International Biotech Limited Stock
Equities
YBGJ
US9883661004
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.8999 USD | -2.17% | +5.87% | +199.97% |
Financials (USD)
Sales 2022 | 0.1 | Sales 2023 | 0.6 | Capitalization | 35.95M |
---|---|---|---|---|---|
Net income 2022 | -1M | Net income 2023 | -1M | EV / Sales 2022 | 116,560,264 x |
Net Debt 2022 | 772K | Net Debt 2023 | 386K | EV / Sales 2023 | 60,084,725 x |
P/E ratio 2022 |
-9.36
x | P/E ratio 2023 |
-30.1
x | Employees | 18 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 6.63% |
1 day | -2.17% | ||
1 week | +24.99% | ||
Current month | +158.07% | ||
1 month | -5.27% | ||
3 months | +199.97% | ||
6 months | +157.85% | ||
Current year | +199.97% |
Managers | Title | Age | Since |
---|---|---|---|
Jun Wang
CEO | Chief Executive Officer | 57 | 18-12-31 |
Lina Liu
DFI | Director of Finance/CFO | 45 | 18-12-31 |
Wang Yang
BRD | Director/Board Member | 45 | 18-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Wang Yang
BRD | Director/Board Member | 45 | 18-12-31 |
Lina Liu
DFI | Director of Finance/CFO | 45 | 18-12-31 |
Zhi Hui Bai
BRD | Director/Board Member | 39 | 19-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-16 | 0.8999 | -2.17% | 28,678 |
24-05-15 | 0.9199 | +8.25% | 4,400 |
24-05-14 | 0.8498 | -2.88% | 4,512 |
24-05-13 | 0.875 | +9.37% | 11,110 |
24-05-10 | 0.8 | -5.88% | 19,940 |
Delayed Quote OTC Markets, May 16, 2024 at 03:23 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+199.97% | 110M | |
+33.37% | 49.46B | |
+1.55% | 42.58B | |
+49.11% | 42.49B | |
-4.22% | 29.09B | |
+11.57% | 26.61B | |
-21.00% | 18.64B | |
+7.36% | 13.16B | |
+28.30% | 12.55B | |
+23.80% | 12.1B |
- Stock Market
- Equities
- YBGJ Stock